Introduction {#S0001}
============

Knee tibiofemoral osteoarthritis (KOA) is a chronic joint disease that imposes significant health care burden.[@CIT0001]--[@CIT0003] The major feature of KOA is joint space narrowing. Together with meniscal pathology, it contributes to articular cartilage loss on knee radiographs.[@CIT0004] Painful knee and knee deformity due to KOA decrease the strength of the thigh muscle.[@CIT0005] Thus, it is important to detect risk factors in earlier stages of joint disorder development. Previous studies have investigated morphological parameters of KOA, including joint space narrowing,[@CIT0004] the vastus medialis cross-sectional area,[@CIT0006] the strength of quadriceps muscle,[@CIT0007],[@CIT0008] and articular cartilage loss. Patellar cartilage loss is also associated with a higher possibility of KOA.[@CIT0009] Patella plays a major role in knee joint function. Abnormality in patella can lead to changes in the knee joint mechanism.[@CIT0010] Cross-talk between cartilage and subchondral bone could induce catabolism of the cartilage of patella.[@CIT0011],[@CIT0012] It may lead to pathological changes in cartilage. The presence of patellar bone marrow lesions in the elderly is associated with changes of patellar cartilage,[@CIT0010] including patellar cartilage defect progression and patellar cartilage volume loss. Patellar cartilage volume loss tends to increase over time. It might be a major risk factor for secondary KOA.[@CIT0013] However, no studies have reported the clinical optimal cutoff value of patellar cartilage loss on KOA. To evaluate the connection between KOA and patellar cartilage loss, we analyzed the patellar cartilage cross-sectional area (PCA). MRI is superior to radiography for detecting patellar cartilage loss \[4\]. Thus, we used knee MRI to compare PCA between KOA patients and normal controls. The objective of this study was to determine whether PCA could be used as an important adjuvant morphological parameter in the diagnosis of KOA. We hypothesize that the cross-sectional area of patellar cartilage is an important morphological parameter in the identification of patellar cartilage loss.

Patients and methods {#S0002}
====================

Patients {#S0002-S2001}
--------

This retrospective research was registered at Catholic Kwandong University (CKU), College of Medicine, Incheon, South Korea. The Institutional Review Board of CKU inspected and approved the study protocol (CKU IRB number: IS18RISI0015). Written informed consent was obtained from each patient involved in this research. This original research followed the Declaration of Helsinki in confidentiality of patient data. We reviewed patients who had visited the Catholic Kwandong Pain Clinic and Orthopedic Center between May 2015 and December 2017 and were diagnosed with KOA. Patients aged above 50 years were included if they had clinical manifestations (stiffness, swelling, pain, a grinding, or grating sensation when moving the joint) compatible with KOA and had knee MRI within 1 year of the diagnosis that was available for chart review. Radiographic KOA was defined by a Kellgren--Lawrence (KL) grade of 2 or 3. Patients were excluded if they had a history of inflammatory arthritis, end-stage of KOA (KL grade 4), complex regional pain syndrome, rheumatoid arthritis, or history of total knee replacement.

A total of 88 patients were enrolled after KOA diagnosis was confirmed by 2 board-certified, experienced musculoskeletal radiologists. The KOA group included 20 (KL grade 2=11, KL grade 3=9) (22.7%) males and 68 (KL grade 2=33, KL grade 3=35) (77.3%) women with a mean age of 58.28±6.67 ears (range, 50--83 years) ([Table 1](#T0001){ref-type="table"}). The PCA of patients with KOA was compared to that of a group of control subjects who had taken knee MRI as part of nonsymptomatic medical examination. Patients in the control group had no KOA-related disease. Control subjects were excluded if they had a history of inflammatory arthritis, complex regional pain syndrome, rheumatoid arthritis, or history of total knee surgery. The control group consisted of 77 patients (23 men and 54 women) with a mean age of 57.13±8.19 years (range, 50--79 years) ([Table 1](#T0001){ref-type="table"}).Table 1Comparison of the characteristics of control and KOA groupVariableControl group, n=77KOA group, n=88Statistical significanceGender (male/female)23/5420/68*p*=0.134BMI (kg/m^2^)29.1±4.828.9±4.3*p*=0.327Age (yrs)57.13±8.1958.28±6.67*p*=0.357PCA (mm^2^)98.66±22.1859.43±16.11*p*\<0.001[^1][^2]

Imaging parameters {#S0002-S2002}
------------------

Knee MRI was performed with 3T Avanto (Siemens Healthcare, Erlangen, Germany) and 3 T scanners (Achieva; Philips Healthcare, The Netherlands). Knee MRI examination was conducted using transverse turbo spin echo (TSE) to obtain fat-suppressed T2-weighted images with a slice thickness \<3.0 mm, repetition time/echo time of 2860-ms/75-ms, field of view of 160×160, and matrix of 448×314. All MRI data were transferred from the MRI unit to an INFINITT system (INFINITT Healthcare Co., Seoul, Korea).

Image analysis {#S0002-S2003}
--------------

Transverse T2-weighted MR images in individual patients were acquired. An INFINITT picture archiving communications system (INFINITT PACS) was used to measure the PCA by outlining the patellar cartilage contour on the T2-weighted MR image with INFINITT system. INFINITT PACS is an image management system offering streamlined reading workflow task and many value-added features. INFINITT PACS also offers an enterprise imaging solution with the diagnostic viewer ([Figure 1](#F0001){ref-type="fig"}).Figure 1Measurement of the patellar cartilage cross-sectional area (PCA) on transverse turbo spin echo fat-suppressed T2-weighted image. (**A**) Control group. (**B**) Knee tibiofemoral osteoarthritis group.

Statistical analysis {#S0002-S2004}
--------------------

Statistical analysis was carried out using the IBM SPSS version 22 for Windows (IBM Corp, New York). Statistical algorithms were used to calculate the SD. *P*-values below 0.05 were considered statistically significant. Using the unpaired *t*-test, we compared the PCA between the KOA and control groups. We use a one-way ANOVA to analyze the correlation between the age-related changes and PCA. The validity of the PCA for diagnosis was calculated using receiver operator characteristic (ROC) curves, sensitivity, and specificity with 95% CIs, optimal cutoff values, area under the curve (AUC).

Results {#S0003}
=======

Demographic characteristics (gender, body mass index, age) were not significantly different between the two groups ([Table 1](#T0001){ref-type="table"}). The average PCA was 98.66±22.18 mm^2^ in the control group and 59.43±16.11 mm^2^ in the KOA group. KOA patients had significantly (*p*\<0.001) lower PCA than control subjects ([Table 1](#T0001){ref-type="table"}). The mean PCA of the control group was 97.92±22.39 mm^2^ in subjects aged 50--59 years, 101.22±18.91 mm^2^ in subjects aged 60--69 years, and 98.92±28.48 mm^2^ in subjects aged 70--79 years ([Table 2](#T0002){ref-type="table"}). There were no statistically significant difference between PCA and age-related morphological changes in one-way ANOVA (F=0.128; df=2; *p*=0.880) in the control group. The mean PCA of KOA group was measured at 57.79±14.98 mm^2^ for patients aged 50--59 years, 61.96±18.28 mm^2^ for patients aged 60--69 years, and 60.38±12.07 mm^2^ for patients aged 70--83 years ([Table 3](#T0003){ref-type="table"}). There were no statistically significant relationships between PCA and age-related changes in the KOA group either (F=0.666; df=2; *p*=0.516). Regarding the validity of PCA as a predictor of KOA, ROC curve analysis showed that the optimal cutoff point of the PCA was 76.06 mm^2^, with sensitivity of 83.0%, specificity of 83.1% ([Table 4](#T0004){ref-type="table"}), and AUC of 0.94 (95% CI: 0.90--0.97) ([Figure 2](#F0002){ref-type="fig"}).Table 2Age distribution of patients with mean PCA of control groupAge distribution (years)Total (N)50--5997.92±22.39 mm^2^ (54)60--69101.22±18.91 mm^2^ (15)70--7998.92±28.48 mm^2^(8)[^3] Table 3Age distribution of patients with mean PCA of KOA groupAge distribution (years)Total (N)50--5957.79±14.98 mm^2^ (52)60--6961.96±18.28 mm^2^ (32)70--8360.38±12.07 mm^2^ (4)[^4] Table 4Sensitivity and specificity of each cutoff point of the PCAPCA (mm^2^)Sensitivity (%)Specificity (%)42.8119.310061.8453.498.771.6675.090.976.06^a^83.083.181.3889.875.387.3996.666.2[^5][^6] Figure 2Receiver operating characteristic (ROC) curve of patellar cartilage cross-sectional area (PCA) for prediction of knee osteoarthritis. The best cutoff point of PCA was 76.06 mm^2^, with sensitivity of 83.0%, specificity of 83.1% and AUC of 0.94. PCA AUC (95% CI) =0.94 (0.90--0.97).**Abbreviation:** AUC, area under the curve.

Discussion {#S0004}
==========

Patellar cartilage defects of the knee are a frequent pathologic condition associated with reduced quality of life and knee pain. Because of their limited healing potential, patellar cartilage defects tend to increase over time and may be considered a major risk factor for KOA.[@CIT0009] KOA characterized by biochemical and structural cartilage abnormalities may ultimately become functionally and symptomatically debilitating.[@CIT0014]--[@CIT0016] Painful knee and knee deformity due to KOA result in reduced muscle strength of the thigh.[@CIT0005] With expectations and hope for early intervention, there is a major interest in finding a reliable and sensitive morphological parameter to identify these biochemical and structural changes at various stages of the KOA.[@CIT0014],[@CIT0017] Previous studies have investigated the association of signs and symptoms of KOA with knee cartilage volume loss,[@CIT0018],[@CIT0019] vastus medialis cross-sectional area,[@CIT0006] mean cartilage thickness over the knee, total subchondral bone area,[@CIT0020] and thigh muscle volumes[@CIT0005] on knee MRI. Yamauchi et al have reported that individual muscle volumes of knee flexors and extensors of patients with KOA can be assessed from a single-slice cross-sectional area using MRI.[@CIT0005] Pan et al have insisted that the number of painful sites can independently predict volume loss of knee cartilage, suggesting that widespread knee pain may be a rapid marker of more early cartilage loss of knee in those without radiographic KOA.[@CIT0018] Buck et al have reported that the subchondral bone and mean cartilage thickness can define an effective subset for detecting structural change in cartilage in KOA.[@CIT0020] However, there are no previous reports correlating KOA and PCA as a morphologic parameter on MRI. In the human body, the patellar cartilage is the thickest cartilage.[@CIT0021] Recurrent patellar instability problems or dislocations can lead to degenerative cartilage changes that can eventually lead to KOA.[@CIT0021] Our results demonstrate that PCA is associated with KOA. The correlation between PCA and KOA is explained by the decrease in PCA associated with an increase in KOA. One explanation for this association is infiltration of inflammatory factors known to be critical contributors to KOA pathogenesis.[@CIT0022] In the pathogenesis of inflammation processes, inflammatory factors such as chemokines, cytokines, proteolytic, prostanoids, vascular growth factors, and enzymes are released. These factors can activate peripheral nociceptors.[@CIT0023] These inflammatory cytokines are associated with matrix degradation and increased cartilage turnover.[@CIT0018] Mostrom et al have insisted that degenerative changes of cartilage are due to altered biomechanics in the femoropatellar joint.[@CIT0021] Repetitive mechanical load is an important for regulating the chondrocytes metabolic activity while deformation of the orientation of the collagen network and cells can stimulate the synthesis of matrix components.[@CIT0024] The instability enhanced by malalignment and loss of congruity can potentially lead to an increased shear stress of the load-bearing area. In the end, this may lead to proteoglycans loss.[@CIT0021] Based on this evidence, a higher level of systemic inflammation can lead to more loss of PCA.

In our study, the best cutoff point for PCA was 76.06 mm^2^, with sensitivity of 83.0%, specificity of 83.1%, and AUC of 0.94 (95% CI: 0.90--0.97). Our findings suggest that PCA is an accurate, objective, and adjuvant morphological parameter for KOA prediction.

In this analysis, we used knee MRI. This is because MRI is a noninvasive, useful, and sensitive method to detect composition changes of cartilage degeneration.[@CIT0025] Knee MRI also has been instrumental in exploring functional adaptation, maintenance, development, and degeneration of articular cartilage, making it possible to extract geometric dimensions of the tissue.[@CIT0020],[@CIT0026] In the analysis of KOA, morphologic measures of cartilage are frequently acquired to assess disease progression or status.[@CIT0020] Metrics of cartilage morphology (thickness, volume) based on knee MRI have been well investigated.[@CIT0027]

Our study only included individuals aged above 50 years. This is because Mosher et al have reported that patella cartilage changes in early KOA may occur mainly and primarily in the superficial layer where collagen matrix first degenerates.[@CIT0028]

The present study had some limitations. First, we could not compare PCA with patients' clinical outcomes such as visual analog scale or knee injury and osteoarthritis outcome score subscales. Previous studies have indicated that clinical outcome is not significantly associated with all morphologic parameters.[@CIT0029] The pathophysiology of KOA is complex. Although the loss of the patellar cartilage is a major factor, inflammatory effects and some other causes such as depression and subjective quality of feeling may also affect pain intensity and unpleasantness.[@CIT0030]--[@CIT0036] Second, there might be measurement errors associated with analyzing the PCA on knee MRI. We measured PCA in axial T2 images. However, these axial images might be inhomogeneous due to differences in cutting angle of knee MR images resulting from technical insufficiency and individual anatomic variations. Third, knee joint cartilage can be assessed anatomically in eight regions (Central lateral femoral condyle, Posterior lateral femoral condyle, Lateral tibial plateau, Trochlea, Central medial femoral condyle, Posterior medial femoral condyle, Medial tibial plateau, and Patella).[@CIT0014] However, this study only used PCA measurement. Therefore, our results might be limited regarding the measurement of other morphologic changes. Fourth, one of the findings of the study is that "there were no statistically significant difference between PCA and age-related morphological changes." However, the distributions of subjects among the three age groups were highly skewed in both KOA and control groups. The majorities of the subjects fall in the age group of 50--59 (N\>50), while only 8 and 4 subjects were in the age group of 70--79 in control and KOA groups, respectively. Due to the extremely small number of subjects in the older age group, the statistical power can be limited to conclude age-related morphological differences among these 3 groups. Fifth, the knee joint is consisted of tibiofemoral joint and patellofemoral joint. However, we did not analyze the relationship between tibiofemoral and patellofemoral joints osteoarthritis. In the future study, we have a plan to investigate the relationship between PCA and both tibiofemoral and patellofemoral joints osteoarthritis. Sixth, our study only included individuals aged above 50 years. Therefore, these results may not be generalized to individuals \<50 years old and early-stage KOA (KL grade 4). Another weakness of this study was its retrospective nature. Despite these limitations, this is the first paper that describes the association of PCA with KOA. These results may facilitate the diagnosis of KOA.

Conclusion {#S0005}
==========

PCA is a new sensitive parameter for the diagnosis of KOA. With a best cut offpoint of 76.06 mm^2^, it had sensitivity of 83.0%, specificity of 83.1%, and AUC of 0.94. We expect that this measurement tool can be used to facilitate the evaluation of patients with KOA.
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[^1]: **Note:** Data represent the mean ± standard deviation or the numbers of patients.

[^2]: **Abbreviations:** KOA, knee tibiofemoral osteoarthritis; BMI, body mass index; PCA, patellar cartilage cross-sectional area; NS, not statistically significant (*p*\>0.05).

[^3]: **Abbreviation:** PCA, patellar cartilage cross-sectional area.

[^4]: **Abbreviations:** PCA, patellar cartilage cross-sectional area; KOA, knee tibiofemoral osteoarthritis.

[^5]: **Note:** ^a^The best cutoff point on the receiver operating characteristic (ROC) curve.

[^6]: **Abbreviation:** PCA, patellar cartilage cross-sectional area.
